ArticleBMC medical imaging2026
Evaluating the feasibility and radiation dose reduction of low-dose computed tomography in radiofrequency ablation for liver tumours.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore the feasibility of using low-dose computed tomography (CT) guidance in the process of radiofrequency ablation (RFA) for the treatment of liver tumours.
methodsIn this study, 150 patients requiring CT-guided RFA for liver tumours were divided into conventional-dose (250 mA, n = 75) and low-dose (50 mA, n = 75) groups based on the guided CT dose. Image quality and radiation dose were compared between the two groups.
resultThe CT images of both groups met the requirements for RFA treatment, and the treatment was successfully completed. The radiation dose parameters in the conventional-dose group were a volume CT dose index of 19.14 ± 7.16 mGy, a dose-length product of 4,987.19 ± 1,679.80 mGy·cm and an effective dose (ED) of 74.81 ± 28.20 mSv. The ED in the low-dose group was 74.8% lower than that in the conventional-dose group (p < 0.05). The CT images of both groups met the requirements for RFA treatment, with the low-dose group exhibiting lower image quality but clear visualisation of the radiofrequency electrode needle in the liver tumours. At the 1–3-month follow-up, the complete ablation rates were comparable between the low-dose (78.86%) and conventional-dose (79.12%) groups (p > 0.05), demonstrating short-term technical success.
conclusionLow-dose CT protocols for guiding RFA may reduce the radiation dose without compromising oncologic outcomes. However, these findings should be interpreted in the context of the short-term (1–3 months) follow-up period, which assessed immediate ablation success but not long-term recurrence rates. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.